公开(公告)号：US09311045B2

公开(公告)日：2016-04-12

申请号：US13597258

申请日：2012-08-29

Applicant: Chih-Ming Chen

Inventor： Chih-Ming Chen

IPC: G11C7/10 ,  G06F5/14

CPC classification number: G06F5/14

Abstract: An elastic buffer module including a memory unit, a write control module, and a read control module is provided. The memory unit receives, stores, and outputs a data sequence from a transmitting side. The write control module removes at least part of auxiliary data from the data sequence and writes the data sequence that has the auxiliary data removed into the memory unit. The read control module reads the data sequence from the memory unit and adds auxiliary data to the data sequence to adjust a write state of the transmitting side and a read state of a receiving side. Additionally, an elastic buffering method of a transmission interface is also provided.

Abstract translation: 提供一种包括存储器单元，写入控制模块和读取控制模块的弹性缓冲器模块。 存储单元从发送侧接收，存储和输出数据序列。 写入控制模块从数据序列中移除辅助数据的至少一部分，并将具有删除的辅助数据的数据序列写入存储器单元。 读取控制模块从存储器单元读取数据序列，并将辅助数据添加到数据序列，以调整发送侧的写入状态和接收侧的读取状态。 此外，还提供了传输接口的弹性缓冲方法。

公开(公告)号：US08846758B2

公开(公告)日：2014-09-30

申请号：US13553271

申请日：2012-07-19

Applicant: Mannching Sherry Ku ,  Chih-Kuang Chen ,  Wei-Shu Lu ,  Chih-Ming Chen ,  I-Yin Lin

Inventor： Mannching Sherry Ku ,  Chih-Kuang Chen ,  Wei-Shu Lu ,  Chih-Ming Chen ,  I-Yin Lin

IPC: A01N37/02 ,  A01N37/10 ,  A61K31/225 ,  C07C50/18 ,  A61K45/06 ,  A61K38/17 ,  A61K31/235

CPC classification number: A61K31/235 ,  A61K38/1793 ,  A61K45/06 ,  Y10S514/866 ,  A61K2300/00

Abstract: Methods for treating abnormal glycosylated hemoglobin (HbA1c) levels in a patient in need thereof, wherein the provided methods comprise administering to a patient in need a therapeutically effective amount of an Interleukin-1β modulator. Also, the invention provides compositions comprising at least one lipid modifying agent and an IL-1β modulator.

Abstract translation: 在有需要的患者中治疗异常糖基化血红蛋白（HbA1c）水平的方法，其中所提供的方法包括向需要的患者施用治疗有效量的白细胞介素-1bib; 调制器。 此外，本发明提供包含至少一种脂质改性剂和IL-1和bgr的组合物; 调制器。

公开(公告)号：US08817464B2

公开(公告)日：2014-08-26

申请号：US13346750

申请日：2012-01-10

Applicant: Maw-Zan Jau ,  Wei-Yi Chu ,  Chao-Jung Chen ,  Tzu-Hung Wang ,  Chih-Ming Chen

Inventor： Maw-Zan Jau ,  Wei-Yi Chu ,  Chao-Jung Chen ,  Tzu-Hung Wang ,  Chih-Ming Chen

IPC: H05K7/20 ,  H05K7/14

CPC classification number: H05K7/1492 ,  H05K7/20136 ,  H05K7/20718

Abstract: A server system includes a rack, a power supply module, a switch, and a plurality of servers. The rack can be divided into a plurality of rack units. The rack units are parallel to each other and vertically arranged. The power supply module and the switch are disposed in close proximity to each other in at least one of the rack units. The power supply is adjacent to the rear side of the rack. The switch is adjacent to the front side of the rack. Each of the servers is disposed in one of the other rack units and electrically connected to the power supply module and the switch.

Abstract translation: 服务器系统包括机架，电源模块，交换机和多个服务器。 机架可分为多个机架单元。 机架单元彼此平行并垂直排列。 电源模块和开关在至少一个机架单元中彼此靠近地设置。 电源靠近机架的后侧。 开关与机架前侧相邻。 每个服务器设置在其他机架单元之一中，并且电连接到电源模块和开关。

公开(公告)号：US08679539B2

公开(公告)日：2014-03-25

申请号：US11700226

申请日：2007-01-31

Applicant: Yu-Der Lee ,  Chi-Yu Huang ,  Chih-Ming Chen

Inventor： Yu-Der Lee ,  Chi-Yu Huang ,  Chih-Ming Chen

IPC: A61K9/14

CPC classification number: A61K9/5138 ,  A61K9/1075 ,  A61K9/5192 ,  A61K31/167 ,  A61K31/37 ,  A61K31/711

Abstract: A process for preparing the drug-loaded cyanoacrylate nanoparticles is described. The cyanoacrylate nanoparticles which effectively deliver biological and therapeutic agents are synthesized by miniemulsion polymerization with surfactant, pluronic F127 or F68. Before initiation of polymerization, active agents with particularly highly hydrophobicity are dissolved in cyanoacrylate monomer. Compared with the drug-loaded polyalkylcyanoacrylate nanoparticles produced by emulsion polymerization, those produced by miniemulsion polymerization possess higher loading and encapsulation efficiencies. While the content of dissolved agents increases, furthermore, the loading and encapsulation efficiencies increase concurrently.

Abstract translation: 描述了制备负载药物的氰基丙烯酸酯纳米颗粒的方法。 通过与表面活性剂pluronic F127或F68的细乳液聚合合成有效递送生物和治疗剂的氰基丙烯酸酯纳米粒子。 在聚合开始之前，具有特别高度疏水性的活性剂溶解在氰基丙烯酸酯单体中。 与通过乳液聚合制备的载药聚氰基丙烯酸甲酯纳米颗粒相比，通过细乳液聚合制备的纳米颗粒具有更高的负载和包封效率。 而溶解剂的含量增加，此外，负载和封装效率同时增加。

公开(公告)号：US08679534B2

公开(公告)日：2014-03-25

申请号：US11355335

申请日：2006-02-16

Applicant: Chih-Ming Chen ,  Joseph Chou ,  David Wong

Inventor： Chih-Ming Chen ,  Joseph Chou ,  David Wong

IPC: A61K9/28 ,  A61K9/36 ,  A61K9/20 ,  A61K31/35

CPC classification number: A61K9/0004 ,  A61K9/2018 ,  A61K9/2031 ,  A61K9/2886 ,  A61K31/22 ,  A61K31/366

Abstract: Controlled release oral solid dosage form for the reduction of serum cholesterol levels in humans include a drug comprising an alkyl ester of hydroxy substituted naphthalenes (e.g., lovastatin) and a controlled release carrier, such that the dosage form provides a mean time to maximum plasma concentration (Tmax) of the drug which occurs at about 10 to about 32 hours after oral administration on a once-a-day basis to human patients. The dosage form provides a therapeutically effective reduction in serum cholesterol levels. Methods of reducing serum cholesterol levels in humans are also disclosed.

Abstract translation: 用于降低人体血清胆固醇水平的控释口服固体剂型包括包含羟基取代萘的烷基酯（例如洛伐他汀）和控释载体的药物，使得该剂型提供了最大血浆浓度的平均时间 （Tmax）在每天一次口服给予人类患者后约10至约32小时发生。 剂型提供治疗有效的降低血清胆固醇水平。 还公开了降低人体血清胆固醇水平的方法。

公开(公告)号：US08536152B2

公开(公告)日：2013-09-17

申请号：US13081548

申请日：2011-04-07

Applicant: Mannching Sherry Ku ,  Danchen Gao ,  Wei-Shu Lu ,  Chih-Ming Chen ,  I-Yin Lin

Inventor： Mannching Sherry Ku ,  Danchen Gao ,  Wei-Shu Lu ,  Chih-Ming Chen ,  I-Yin Lin

IPC: A61K31/715

CPC classification number: A61K31/225 ,  A61K31/145 ,  A61K31/155 ,  A61K31/277 ,  A61K31/426 ,  A61K31/427 ,  A61K38/28 ,  A61K45/06 ,  A61K2300/00

Abstract: The present invention provides methods of treating type II diabetes using combinations of diacerein or its derivatives with other antidiabetic agents. The methods may also allow improving glycemic control of type II diabetes patients and/or reducing side effects and/or cardiovascular risks of antidiabetic agents.

Abstract translation: 本发明提供了使用双醋瑞因或其衍生物与其它抗糖尿病药物的组合治疗II型糖尿病的方法。 该方法还可以改善II型糖尿病患者的血糖控制和/或减少抗糖尿病药物的副作用和/或心血管风险。

公开(公告)号：US20130227543A1

公开(公告)日：2013-08-29

申请号：US13477066

申请日：2012-05-22

Applicant: Chih-Ming Chen

Inventor： Chih-Ming Chen

IPC: G06F9/44

CPC classification number: G06F8/654 ,  G06F8/65

Abstract: A server deployment system and a method for updating data are provided. A system management server is added to the server deployment system for providing an update data. In a server system, a main server receives the update data from the system management server. The update data includes a controller firmware and a main server software. A firmware updating instruction is transmitted to a device controller to allow the device controller to update its original firmware into the controller firmware. If the controller firmware is successfully updated, the main server updates its original software into the main server software. If the main server software is not successfully updated, a firmware rollback instruction is transmitted to the device controller to allow the device controller to rollback to its original firmware. If the main server software is successfully updated, the system management server is notified.

Abstract translation: 提供了服务器部署系统和更新数据的方法。 系统管理服务器被添加到服务器部署系统以提供更新数据。 在服务器系统中，主服务器从系统管理服务器接收更新数据。 更新数据包括控制器固件和主服务器软件。 固件更新指令被发送到设备控制器以允许设备控制器将其原始固件更新为控制器固件。 如果控制器固件成功更新，主服务器将其原始软件更新为主服务器软件。 如果主服务器软件未成功更新，则将固件回滚指令传输到设备控制器，以允许设备控制器回滚到其原始固件。 如果主服务器软件成功更新，则会通知系统管理服务器。

公开(公告)号：US08513790B2

公开(公告)日：2013-08-20

申请号：US12428342

申请日：2009-04-22

Applicant: Chih-Ming Chen ,  Deng-Huei Hwang ,  Ching-Chi Cheng

Inventor： Chih-Ming Chen ,  Deng-Huei Hwang ,  Ching-Chi Cheng

IPC: H01L33/00

CPC classification number: H01L33/62 ,  H01L33/483 ,  H01L33/642 ,  H01L2224/48091 ,  H01L2224/48227 ,  H01L2924/00014

Abstract: A package-base structure of a luminescent diode and its fabricating process. The package-base structure includes a substrate having thereon a holding space; an insulating layer extending from a bottom surface of the holding space to the bottom of the substrate; an through hole defined in the insulating layer; and a conductive layer disposed over the insulating layer. The insulating layer decouples the current flow and heat flow to increase the lifetime of the package-base structure together with the luminescent diode. In the fabricating process, the insulating layer is formed by anodic etching to allow the insulating layer have a porous structure.

Abstract translation: 发光二极管的封装基础结构及其制造工艺。 封装体结构包括其上具有保持空间的基板; 绝缘层，其从所述保持空间的底表面延伸到所述基板的底部; 绝缘层中限定的通孔; 以及设置在所述绝缘层上的导电层。 绝缘层将电流和热流分离，以增加封装 - 基极结构与发光二极管的寿命。 在制造过程中，通过阳极蚀刻形成绝缘层，以使绝缘层具有多孔结构。

公开(公告)号：USD683785S1

公开(公告)日：2013-06-04

申请号：US29438040

申请日：2012-11-26

Applicant: Chih-Ming Chen

Designer： Chih-Ming Chen

公开(公告)号：US20130075839A1

公开(公告)日：2013-03-28

申请号：US13244349

申请日：2011-09-24

Applicant: Chih-Ming Chen ,  Ya-Chen Kao ,  Ming-Te Liu ,  Chung-Yi Yu ,  Cheng-Yuan Tsai ,  Chun-Jung Lin

Inventor： Chih-Ming Chen ,  Ya-Chen Kao ,  Ming-Te Liu ,  Chung-Yi Yu ,  Cheng-Yuan Tsai ,  Chun-Jung Lin

IPC: H01L29/82 ,  H01L21/8246

CPC classification number: H01L43/12 ,  G11C11/15 ,  G11C11/161 ,  H01L43/08

Abstract: The present disclosure provides a MTJ stack for an MRAM device. The MTJ stack includes a pinned ferromagnetic layer over a pinning layer; a tunneling barrier layer over the pinned ferromagnetic layer; a free ferromagnetic layer over the tunneling barrier layer; a conductive oxide layer over the free ferromagnetic layer; and a oxygen-based cap layer over the conductive oxide layer.

Abstract translation: 本公开提供了一种用于MRAM设备的MTJ堆叠。 MTJ堆叠包括钉扎层上的钉扎铁磁层; 在被钉扎铁磁层上的隧道势垒层; 在隧道势垒层上的自由铁磁层; 在自由铁磁层上的导电氧化物层; 以及在导电氧化物层上的氧基覆盖层。